
What is Ketamine?
Ketamine (2-chlorophenyl-2-methylamino-cyclohexanone) is a derivative of phencyclidine (PCP), first synthesized by Calvin Stevens in 1962 at the Parke-Davis Pharmaceutical Company (1). Originally designed as a fast-acting anesthetic, ketamine is now widely used in medical and veterinary settings. Its unique ability to induce anesthesia without significantly affecting the respiratory or circulatory systems made it invaluable in trauma care.
Over time, ketamine became more than just a medical tool; its potent dissociative effects, including hallucinations and out-of-body experiences, contributed to its rise as a recreational drug (2). However, ketamine’s impact on brain chemistry has also led to significant interest in its potential therapeutic uses, especially in mental health treatment.
Esketamine, Arketamine and Racemic Ketamine: The Dual Nature of Ketamine's Isomers
Ketamine is composed of two mirror-image isomers: Like the hands; the left handed version of ketamine S-ketamine (esketamine) and the right handed version R-ketamine (arketamine) (6). These isomers interact with the brain differently, which has important implications for their medical applications.
- Esketamine: This isomer has been FDA-approved for treatment-resistant depression under the brand name Spravato® (4). Esketamine is faster-acting and often induces dissociative experiences, which can include hallucinations and ego dissolution. These effects may help patients break out of harmful mental patterns, especially when used in conjunction with psychotherapy.
- Arketamine: Although not yet FDA-approved, arketamine is showing promise in clinical trials for treating depression. Unlike esketamine, arketamine appears to have a longer-lasting antidepressant effect with fewer dissociative side effects (6). Some researchers believe that arketamine may offer more significant benefits in terms of neuroplasticity, the brain’s ability to reorganize itself.
- Racemic Ketamine: Conventional ketamine typically comes as a racemic mixture, which means it contains equal parts of both isomers (50:50): R-ketamine and S-ketamine. The combined effects of the two isomers can vary, as they may interact with different receptors in the brain, leading to a range of psychoactive and anesthetic effects. Recreational ketamine however, the proportions of R and S isomers may vary, particularly if the substance is synthesized or adulterated outside of controlled environments. This could lead to a mixture that is not exactly equal, potentially impacting the effects experienced by the user.

Figure: https://pubmed.ncbi.nlm.nih.gov/33155503/#&gid=article-figures&pid=figure-1-uid-0
Chemical structure of ketamine enantiomers. (S)-ketamine and (R)-ketamine are a pair of stereoisomers that are non-superimposable mirror images of each other. An example of familiar objects that are related in such a way are the left and right hand.
The History of Ketamine: From Anesthetic to Therapy
Ketamine’s initial approval by the U.S. FDA in the 1970s was for its use as an anesthetic, and it quickly became a vital tool in emergency surgery, especially in trauma cases (2). Its rapid onset and short recovery time made it ideal for inducing anesthesia in high-risk situations.
However, ketamine’s potential extends beyond its anesthetic properties. In recent decades, researchers have explored its use in mental health treatments, particularly for treatment-resistant depression. Unlike conventional antidepressants that can take weeks to show results, ketamine has been found to provide rapid relief, sometimes within hours (3). This breakthrough has redefined how severe depression is treated. Despite its dual role as a recreational drug, ketamine’s promise as a therapeutic tool is growing.
Ketamine’s Therapeutic Uses: Beyond Anesthesia
Although originally developed for its anesthetic properties, ketamine’s range of applications has expanded significantly, particularly in the mental health field. Some of its key uses include:
- Depression and Anxiety: Ketamine is now widely used off-label to treat treatment-resistant depression and other mental health conditions. Low doses, administered intravenously or as esketamine via nasal spray, have shown remarkable efficacy in reducing depressive symptoms quickly (4).
- Chronic Pain: Ketamine is also employed as a pain management tool, particularly as an alternative to opioids. Its ability to block NMDA receptors helps reduce pain without the addiction risks associated with opioids (5).
- Asthma: Studies suggest that ketamine may help in acute asthma attacks due to its bronchodilatory effects, providing relief in situations where other medications fail (6).
- PTSD: Although still in the experimental phase, ketamine is being investigated as a potential treatment for post-traumatic stress disorder (PTSD). Its dissociative properties might help patients distance themselves from traumatic memories (6).
Risks and Side Effects of Ketamine
Despite its therapeutic benefits, ketamine carries certain risks, especially when misused. Its side effects can vary depending on the dose and duration of use.
Short-term Side Effects: At low, therapeutic doses, ketamine can cause side effects such as dizziness, nausea, and dissociative experiences. These effects tend to be short-lived but can still be challenging for some patients (3).
Long-term Risks: Prolonged or high-dose use of ketamine, particularly in recreational settings, can result in serious side effects, including cognitive impairment, liver damage, and bladder toxicity (2). Chronic recreational use can lead to ketamine cystitis, a condition that causes severe bladder damage.
Recreational Use of Ketamine: A Growing Concern
The recreational use of ketamine has increased significantly over the past decades. On the street, ketamine is commonly referred to as “Special K”, “K”, or “Vitamin K” (2). Users often seek its dissociative effects, which can include intense hallucinations and a sense of detachment from reality.
However, recreational use is fraught with dangers. Ketamine can cause neurological damage, mental health problems, and bladder toxicity, especially when used regularly or in high doses. The European Union has reported a sharp rise in ketamine seizures, with quantities tripling between 2021 and 2022 (5). Street ketamine is often mixed with other substances, such as MDMA and cocaine, which increases the risk of toxic interactions. It is commonly sold in these mixtures, sometimes labeled as "tusy," as discussed in our recent post (check on our blog: What is Tusy? for more information about this topic).

Ketamine Analysis: How can I test for Ketamine? Test for Ketamine Isomers
Ketamine is sold as a white powder and it can often be adulterated with various substances, and its concentration may vary, as well as the mixture of its isomers depending on the source of the ketamine, leading to unexpected effects for users. On the black market, ketamine sold is primarily the same substance used in medical and veterinary settings, known as racemic ketamine. This form consists of a 50/50 mixture of its two isomers, S-ketamine and R-ketamine. While racemic ketamine is commonly used for anesthesia and pain management, its illicit use often differs in dosage and context, leading to various effects and potential risks.As you can see, this substance presents a high possibility of variability, making analysis increasingly important.
Currently, recreational users can analyze ketamine through colorimetric tests. At Mitaculix, we are working diligently to provide a Ketamine QTest that can measure the concentration of ketamine in samples, and we hope to achieve this in the near future.
On the other hand, there are only a few analytical methods available:
- Chiral Chromatography: This method is specifically designed to separate chiral compounds, allowing for the differentiation between R and S isomers.
- Gas Chromatography-Mass Spectrometry (GC-MS): A highly accurate method that can identify and quantify ketamine and its isomers, with fragmentation patterns helping to differentiate between R and S isomers.
- High-Performance Liquid Chromatography (HPLC): Effective for separating and quantifying isomers, providing detailed information about the composition of a ketamine sample.
- Infrared Spectroscopy (IR): Can identify functional groups in ketamine but may not differentiate between isomers.
As you can see, these tests are costly and difficult to access for determining the composition of each isomer. In any case, we always recommend sending your samples to a laboratory that can analyze their composition, in addition to conducting colorimetric tests yourself. Having this information could significantly reduce potential harm.
Ketamine's Future in Mental Health: The Pipeline of New Therapies
As we already mentioned, looking forward, ketamine’s potential in treating mental health conditions continues to expand. New therapies are being developed and tested in clinical trials, with a particular focus on ketamine’s derivatives, such as arketamine.
Pharmaceutical companies are also exploring alternative delivery methods, seeking to maximize the therapeutic benefits of ketamine while minimizing its side effects. Arketamine, in particular, shows promise for its longer-lasting antidepressant effects and fewer dissociative symptoms (6).
Researchers are also looking at combination therapies, pairing ketamine with psychotherapy to enhance the therapeutic outcomes. This approach could prove valuable in creating sustained relief from symptoms for patients with severe mental health conditions.

Conclusion: The Dual Nature of Ketamine
Ketamine presents a unique case in modern medicine. On the one hand, it offers groundbreaking potential for treating mental health conditions like depression and PTSD; on the other, its recreational use poses significant risks to both individuals and public health.
As research continues to unveil ketamine’s benefits and risks, it will be critical to find the balance between leveraging its therapeutic potential and preventing abuse. With ongoing development of new therapies and closer regulation, ketamine could become a key player in the future of mental health treatment.
References:
(1) Savić Vujović K, Jotić A, Medić B, Srebro D, Vujović A, Žujović J, Opanković A, Vučković S. Ketamine, an Old-New Drug: Uses and Abuses. Pharmaceuticals (Basel). 2023 Dec 21;17(1):16. doi: 10.3390/ph17010016. PMID: 38276001; PMCID: PMC10820504.
(2)Sanctuary Lodge. Ketamine vs Medical Ketamine. https://www.sanctuarylodge.com/blog/medicine/ketamine-vs-medical-ketamine/
(3) Savić Vujović K, Jotić A, Medić B, Srebro D, Vujović A, Žujović J, Opanković A, Vučković S. Ketamine, an Old–New Drug: Uses and Abuses. Pharmaceuticals 2024, 17, 16. https://doi.org/10.3390/ph17010016
(4) National Institute on Drug Abuse. Ketamine Research. https://nida.nih.gov/research-topics/ketamine
(5) European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2024. https://www.euda.europa.eu/publications/european-drug-report/2024/other-drugs_en
(6) Nushama. S-Ketamine vs R-Ketamine: What’s the Difference? https://nushama.com/post/s-ketamine-vs-r-ketamine/